Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Matter Neuroscience Launches With $26M

2024-02-27
NEW YORK, NY, Matter Neuroscience emerges from stealth mode today with $26 million.
Matter Neuroscience, the company working to unlock a deeper understanding of happiness and well-being by providing people with personalized insights into their brain chemistry emerges from stealth mode today. Matter announced it has received $26 million in funding, initial funding seeded by Polaris Partners and a more recent round co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined by Collaborative Fund and others. With this backing, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.

Matter Neuroscience was founded in 2019 by Axel Bouchon and Ben Goldhirsh. Chris Shiflett joined in 2021 as co-founder. Matter's mission is to use neuroscience to help people live longer, healthier, happier lives so that individually, we can reach our full potential, and collectively, we can solve the world's most pressing problems. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners). Matter's COO is Bridget Best (Kickstarter, Sweeten). Ben Goldhirsh (GOOD Worldwide and the Goldhirsh Foundation) serves as Matter's Chairman.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors